News & Updates

Show Multimedia Only

Metformin medication not protective against age-related macular degeneration

02 Jan 2023

Treatment with metformin, along with lifestyle changes, initiated for the prevention of diabetes does not appear to reduce the risk of age-related macular degeneration, a study has found.

Metformin medication not protective against age-related macular degeneration

02 Jan 2023

Investigational drug for dry eye disease scores high in phase III study

01 Jan 2023

Treatment with the NOV03 (perfluorohexyloctane) ophthalmic drop is well tolerated and yields significant improvements in the signs and symptoms of dry eye disease (DED) associated with meibomian gland dysfunction, according to the results of a phase III study.

Investigational drug for dry eye disease scores high in phase III study

01 Jan 2023

$Parental astigmatism a risk factor for refractive, corneal astigmatism in children$

Parental astigmatism a risk factor for refractive, corneal astigmatism in children

31 Dec 2022

Children born to parents with astigmatism are likely to develop refractive or corneal astigmatism, according to a study, suggesting that parental astigmatism has an independent and dose-dependent association with child astigmatism.

Parental astigmatism a risk factor for refractive, corneal astigmatism in children

31 Dec 2022

Frailty-related endogenous endophthalmitis tied to higher in-hospital death, resource use

24 Dec 2022

Frailty syndrome is an independent predictor of endogenous endophthalmitis (EE) development in the setting of bacterial septicemia, suggests a recent study. Furthermore, frailty-induced EE tends to occur in patients with malnutrition and certain bacterial subtypes and may lead to greater in-hospital death and healthcare resource usage.

Frailty-related endogenous endophthalmitis tied to higher in-hospital death, resource use

24 Dec 2022

Lenadogene nolparvovec safe in patients with Leber hereditary optic neuropathy

18 Dec 2022

Lenadogene nolparvovec is well tolerated among patients with Leber hereditary optic neuropathy, being associated with mostly mild ocular side effects that can be resolved with conventional ophthalmologic treatments, according to the results of the LHON study.

Lenadogene nolparvovec safe in patients with Leber hereditary optic neuropathy

18 Dec 2022

Novel topical dexamethasone formulation reduces inflammation, pain after cataract surgery

17 Dec 2022

OCS-01, a topical dexamethasone 1.5% in a novel formulation, appears to be safe and effective in the management of inflammation and pain following cataract surgery, a study has found.

Novel topical dexamethasone formulation reduces inflammation, pain after cataract surgery

17 Dec 2022

$Eyesight worsens with age in patients with diffractive multifocal intraocular lenses$

Eyesight worsens with age in patients with diffractive multifocal intraocular lenses

26 Nov 2022

In patients with diffractive multifocal intraocular lenses (MIOL), age is associated with worse visual acuity (VA) and area-of-focus (AoF), a recent study has found.

Eyesight worsens with age in patients with diffractive multifocal intraocular lenses

26 Nov 2022

Tacrolimus immunosuppression safe in kids with penetrating keratoplasty

24 Nov 2022

Among children with penetrating keratoplasty, using oral tacrolimus for postoperative immunosuppression is safe, with encouraging rates of rejection-free survival and overall graft survival, a recent study has found.

Tacrolimus immunosuppression safe in kids with penetrating keratoplasty

24 Nov 2022

Varenicline nasal spray improves bilateral tear production in dry eye disease

07 Nov 2022

Treatment with OC-01 (varenicline solution) nasal spray in patients with dry eye results in a substantial increase in tear production in the study eyes as well as in milder presenting nonstudy fellow eyes, according to data from the ONSET-1* and ONSET-2 trials.

Varenicline nasal spray improves bilateral tear production in dry eye disease

07 Nov 2022

Small-volume eye drop device on par with SOC in kids

04 Nov 2022 by

A commercially available eye drop adapter device, dubbed the Nanodropper, results in comparable pupil diameter as standard of care (SOC) for routine pupillary dilation in paediatric patients, according to a recent study.

Small-volume eye drop device on par with SOC in kids

04 Nov 2022

News & Updates

Filter by Specialty:

Specialty:

Metformin medication not protective against age-related macular degeneration

Metformin medication not protective against age-related macular degeneration

Investigational drug for dry eye disease scores high in phase III study

Investigational drug for dry eye disease scores high in phase III study

Parental astigmatism a risk factor for refractive, corneal astigmatism in children

Parental astigmatism a risk factor for refractive, corneal astigmatism in children

Frailty-related endogenous endophthalmitis tied to higher in-hospital death, resource use

Frailty-related endogenous endophthalmitis tied to higher in-hospital death, resource use

Lenadogene nolparvovec safe in patients with Leber hereditary optic neuropathy

Lenadogene nolparvovec safe in patients with Leber hereditary optic neuropathy

Novel topical dexamethasone formulation reduces inflammation, pain after cataract surgery

Novel topical dexamethasone formulation reduces inflammation, pain after cataract surgery

Eyesight worsens with age in patients with diffractive multifocal intraocular lenses

Eyesight worsens with age in patients with diffractive multifocal intraocular lenses

Tacrolimus immunosuppression safe in kids with penetrating keratoplasty

Tacrolimus immunosuppression safe in kids with penetrating keratoplasty

Varenicline nasal spray improves bilateral tear production in dry eye disease

Varenicline nasal spray improves bilateral tear production in dry eye disease

Small-volume eye drop device on par with SOC in kids

Small-volume eye drop device on par with SOC in kids